New drug trial aims to tame debilitating Muscle-Weakening disease
Disease control
Recruiting now
This study is testing a new drug called IM-101 to see if it is safe and if it can help control symptoms in adults with myasthenia gravis, a disease that causes severe muscle weakness. The trial will involve about 96 participants and will compare the effects of the drug to a place…
Phase: PHASE1, PHASE2 • Sponsor: ImmunAbs Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC